ASCEND BY NTHRYS
Research Abroad Products

Molecular Pharmacology Project Topics

Browse all focused areas across all project categories under this field.

Showing 73–84 of 200 project topics
Histone Acetyltransferase Modulator Discovery Toolkit
An integrated software and wet-lab toolkit delivering HAT-specific assays, structural databases, and AI-driven hit prediction for activator identification. This comprehensive product enables pharma clients to launch HAT-focused programs independently, opening a new $2.5M+ annual licensing revenue stream.
Epigenetic Target Molecular Pharmacology Tools Click to view more details →
Chromatin Remodeling Complex Target Validation Platform
A sophisticated biophysical and cellular screening platform enabling rapid validation of SWI/SNF and BAF complex inhibitors with selectivity profiling. This platform reduces false positive rates by 70%, accelerates partner hit-to-lead progression, and generates milestone-based licensing fees exceeding $500K per program.
Epigenetic Target Molecular Pharmacology Tools Click to view more details →
Polycomb Repressive Complex Inhibitor Development Software
A predictive computational platform integrating structure-activity relationship modeling and cellular phenotype prediction for PRC1/PRC2 inhibitors. The software''s machine learning algorithms reduce experimental cycles by 50%, providing clients with an 18-month competitive advantage and supporting recurring annual licensing agreements.
Epigenetic Target Molecular Pharmacology Tools Click to view more details →
Lysine Demethylase Selectivity Profiling Service Network
A distributed testing service offering comprehensive KDM isoform selectivity panels and off-target liability screening using proprietary biochemical and cell-based assays. This specialized offering commands 25-35% premium pricing in the oncology market while establishing long-term partnerships with top-20 pharma companies.
Epigenetic Target Molecular Pharmacology Tools Click to view more details →
Bromodomain and Extraterminal Protein Binding Prediction Engine
An AI-powered SaaS platform utilizing quantum chemistry and molecular dynamics to predict BET protein binding affinities and selectivity profiles for new chemical series. This engine reduces synthesis cycles and accelerates scaffold optimization, generating $3-5M annual recurring revenue from premium tier users.
Epigenetic Target Molecular Pharmacology Tools Click to view more details →
Epigenetic Biomarker Discovery and Validation Consortium Platform
A collaborative multi-omics platform combining methylation, histone modification, and chromatin accessibility data analysis with clinical phenotype correlation. This consortium model generates membership fees, data licensing revenue, and integration partnerships valued at $8-12M annually across 50+ participating institutions.
Epigenetic Target Molecular Pharmacology Tools Click to view more details →
CRISPR-Based Epigenetic Target Interrogation Service Suite
A comprehensive service platform delivering dCas9-based CRISPR epigenome editing for target validation, functional genomics, and mechanism-of-action studies. This cutting-edge service differentiates client programs, commands premium pricing at $250K+ per project, and supports rapid expansion into personalized medicine applications.
Epigenetic Target Molecular Pharmacology Tools Click to view more details →
Epigenetic Drug Toxicology and Safety Prediction Platform
An advanced in vitro platform combining differentiated human cell models with high-content screening to predict epigenetic drug off-target toxicity and developmental effects. This predictive tool reduces late-stage clinical failures by 30%, generating significant cost savings and supporting accelerated regulatory pathways through FDA qualification partnerships.
Epigenetic Target Molecular Pharmacology Tools Click to view more details →
High-Throughput Binding Kinetics SaaS Platform
Cloud-based platform that automates surface plasmon resonance (SPR) and biolayer interferometry (BLI) data analysis for rapid drug-target interaction profiling. Reduces assay turnaround time by 60% and enables pharma clients to prioritize lead compounds faster, driving premium subscription revenue.
Molecular Pharmacology CRO Service Platforms Click to view more details →
AI-Powered ADME Prediction and Optimization Tool
Machine learning software that predicts absorption, distribution, metabolism, and excretion properties for drug candidates using proprietary algorithms trained on proprietary datasets. Eliminates costly wet-lab ADME screening cycles and monetizes through per-compound licensing and enterprise SaaS contracts.
Molecular Pharmacology CRO Service Platforms Click to view more details →
Receptor Selectivity Profiling and Screening Service
Integrated CRO service offering comprehensive off-target binding assessment across 50+ human receptors using automated patch-clamp and radiometric assays. Generates high-margin recurring revenue through project-based contracts and reduces client development risk in regulatory submissions.
Molecular Pharmacology CRO Service Platforms Click to view more details →
Real-Time Molecular Docking and Virtual Screening Engine
High-performance computing platform that executes structure-based virtual screening against proprietary and custom protein targets with millisecond latency. Monetizes through cloud computing credits, API access fees, and early partnerships with biotech companies seeking accelerated lead discovery.
Molecular Pharmacology CRO Service Platforms Click to view more details →